{"meta":{"query_hash":"60779a365b15","filters":{"venue":"Recent Patents on Anti-Infective Drug Discovery"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/60779a365b15","api":"https://metacan.xera.ac/api/v1/cohort?venue=Recent+Patents+on+Anti-Infective+Drug+Discovery"},"results":[{"id":"W1981099638","doi":"10.2174/157489106778777592","title":"Poxvirus Cancer Therapy","year":2006,"lang":"en","type":"review","venue":"Recent Patents on Anti-Infective Drug Discovery","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cancer; Medicine; Intensive care medicine; Internal medicine","score_opus":0.06156867199123096,"score_gpt":0.35590404474811965,"score_spread":0.2943353727568887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981099638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015907659,0.98440146,0.000008989538,0.000040118874,0.002797368,0.0019044254,0.002387213,0.00015355385,0.0067161233],"genre_scores_gemma":[0.00044962735,0.98431486,9.2271495e-7,0.00022810769,0.0002398415,0.00045810195,0.002273067,0.00016044338,0.0118750185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99493253,0.0013292492,0.0008421477,0.0012824683,0.00022659518,0.001387007],"domain_scores_gemma":[0.9979343,0.00039876296,0.00059266033,0.00081410055,0.00016305913,0.000097136435],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039571835,0.0011533288,0.0025641893,0.00059319165,0.0003591237,0.0001692707,0.00074661506,0.00080666726,0.0010716326],"category_scores_gemma":[0.00008651394,0.000811767,0.0011981481,0.0006130851,0.00034514524,0.0003512623,0.00024987466,0.0016576904,0.004383035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011979654,0.0010040816,0.00040822383,0.0009064645,0.0015217552,0.000041356547,0.00002321369,0.0000023825928,0.00017035531,0.0001226563,0.02251047,0.97316927],"study_design_scores_gemma":[0.0014172541,0.00014738238,0.00072184094,0.003951596,0.00025456704,0.0000152277635,0.000009294036,1.2951234e-7,0.0015203779,0.000030079427,0.9910628,0.00086943904],"about_ca_topic_score_codex":0.0017650967,"about_ca_topic_score_gemma":0.000119732686,"teacher_disagreement_score":0.9722998,"about_ca_system_score_codex":0.0006553208,"about_ca_system_score_gemma":0.00076555135,"threshold_uncertainty_score":0.9998415},"labels":[],"label_agreement":null},{"id":"W2075758441","doi":"10.2174/157489109788490307","title":"Social Leverage of Intellectual Property: Road to the Development of Better Therapy for Tuberculosis","year":2009,"lang":"en","type":"review","venue":"Recent Patents on Anti-Infective Drug Discovery","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Johnson and Johnson; University of British Columbia","keywords":"Intellectual property; Leverage (statistics); Tuberculosis; Clinical trial; Drug development; Medicine; Investment (military); Business; Risk analysis (engineering); Engineering ethics; Drug; Intensive care medicine; Political science; Engineering; Pharmacology; Computer science; Law; Pathology","score_opus":0.0934556450456633,"score_gpt":0.3615809840344358,"score_spread":0.2681253389887725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075758441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009191671,0.980243,0.0013480461,0.0009335508,0.001138825,0.005630854,0.00071669987,0.000037658952,0.0007596681],"genre_scores_gemma":[0.0025159633,0.995213,0.0001891466,0.0006064448,0.00008927564,0.0001846994,0.0002236772,0.000054450775,0.0009233494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968336,0.0008725031,0.0010480013,0.00063020794,0.00013178002,0.0004838695],"domain_scores_gemma":[0.9983692,0.00053708,0.0005049364,0.00033873427,0.00021881836,0.0000311986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008511281,0.00059362553,0.0020572196,0.00024399198,0.00022554859,0.000029763456,0.00048485308,0.0004803476,0.00012533132],"category_scores_gemma":[0.00025112045,0.00028079387,0.0009440647,0.00043452086,0.00019583745,0.00006968805,0.00015055038,0.00049319706,0.000048464164],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021602087,0.0008935587,0.000025667567,0.00078046776,0.0016308655,3.7702208e-7,0.0005841266,2.840827e-7,0.00040990338,0.000030191051,0.0042491043,0.9911794],"study_design_scores_gemma":[0.0006683174,0.000422571,0.00070479035,0.0021899277,0.00043682326,0.0000019257734,0.00005841964,3.6643542e-7,0.01690204,0.00002059691,0.97816277,0.0004314783],"about_ca_topic_score_codex":0.00001394335,"about_ca_topic_score_gemma":0.000008616605,"teacher_disagreement_score":0.9907479,"about_ca_system_score_codex":0.00016722381,"about_ca_system_score_gemma":0.00030625155,"threshold_uncertainty_score":0.9999644},"labels":[],"label_agreement":null},{"id":"W2123387687","doi":"10.2174/1574891x10666150410130425","title":"Geographical and Occupational Aspects of Leptospirosis in the Coffee-Triangle Region of Colombia, 2007-2011","year":2015,"lang":"en","type":"article","venue":"Recent Patents on Anti-Infective Drug Discovery","topic":"Leptospirosis research and findings","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leptospirosis; Geography; Population; Epidemiology; Agriculture; Quarter (Canadian coin); Incidence (geometry); Socioeconomics; Thematic map; Demography; Environmental health; Veterinary medicine; Cartography; Medicine","score_opus":0.035447472322222756,"score_gpt":0.273853059121905,"score_spread":0.23840558679968224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123387687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959175,0.0010754195,0.000031795687,0.0003010842,0.00029839444,0.00054286583,0.00010754716,0.000010890122,0.0017144744],"genre_scores_gemma":[0.9980624,0.0015369975,0.0000032795006,0.00013154843,0.000017477312,0.00002741251,0.000118632146,0.000011727202,0.00009053831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982287,0.00050673174,0.00037782517,0.0003417701,0.00019083486,0.00035410214],"domain_scores_gemma":[0.9989733,0.00029248177,0.00024465963,0.00024401749,0.0002007791,0.00004473202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007190903,0.00018706475,0.00042280115,0.00029748087,0.000078064644,0.00002485087,0.00022650724,0.00017172468,0.0000651643],"category_scores_gemma":[0.0003376382,0.00013324604,0.00012587837,0.0003402868,0.0005203058,0.00025096373,0.000105906256,0.0003476513,0.000048116202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008745985,0.0015970913,0.9742282,0.000033324202,0.00012336827,0.000008185841,0.00057877484,0.0000058596534,0.012532564,0.0043471404,0.0039430023,0.0017278661],"study_design_scores_gemma":[0.0033186143,0.0007390862,0.960282,0.000093055685,0.00002880537,0.000010175625,0.00053446664,0.0000029518962,0.032205913,0.00072849274,0.0018954463,0.00016097081],"about_ca_topic_score_codex":0.0007381207,"about_ca_topic_score_gemma":0.0000738028,"teacher_disagreement_score":0.01967335,"about_ca_system_score_codex":0.00007054386,"about_ca_system_score_gemma":0.00013747918,"threshold_uncertainty_score":0.54336154},"labels":[],"label_agreement":null},{"id":"W2134917687","doi":"10.2174/157489107780832622","title":"Recent Patents on Development of Nucleic Acid-based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections","year":2007,"lang":"en","type":"review","venue":"Recent Patents on Anti-Infective Drug Discovery","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Neuraminidase; Oseltamivir; Pandemic; Virology; Influenza A virus subtype H5N1; Virus; Nucleic acid; Zanamivir; Influenza A virus; Biology; Medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.05228471400645406,"score_gpt":0.33355226708437613,"score_spread":0.28126755307792206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134917687","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6638145,0.33269143,0.00009522599,0.0000064760484,0.000872748,0.0011334061,0.0005455131,0.000039862323,0.0008008612],"genre_scores_gemma":[0.08544718,0.9119091,0.000025969843,0.0004982683,0.00017499656,0.00010007873,0.0016355792,0.00011834061,0.000090470836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956753,0.0004262672,0.0011873823,0.0013468679,0.00060671265,0.0007574335],"domain_scores_gemma":[0.9978078,0.00009777491,0.00088136346,0.0006570763,0.0003338877,0.00022207129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005721397,0.001079546,0.001513098,0.00052165514,0.00027308302,0.00011486191,0.0003891012,0.00063708477,0.000023196973],"category_scores_gemma":[0.00014165502,0.00091707904,0.0006228659,0.00047238948,0.00023062582,0.000043539178,0.00030629284,0.00066423067,0.00010069206],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002846108,0.0016308787,0.0076521127,0.0013468509,0.0009076961,0.000013312376,0.00007225527,0.00003563416,0.0043905657,0.000006828197,0.0003539092,0.98330534],"study_design_scores_gemma":[0.001973674,0.0008566538,0.0043385657,0.008816805,0.00042115364,0.0000059499157,0.00007601301,0.000013562358,0.057990298,0.0000054774246,0.9239241,0.0015777772],"about_ca_topic_score_codex":0.000016269734,"about_ca_topic_score_gemma":0.000042156436,"teacher_disagreement_score":0.98172754,"about_ca_system_score_codex":0.00036810862,"about_ca_system_score_gemma":0.00084458553,"threshold_uncertainty_score":0.99932796},"labels":[],"label_agreement":null},{"id":"W2138614534","doi":"10.2174/157489112801619674","title":"The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management","year":2012,"lang":"en","type":"review","venue":"Recent Patents on Anti-Infective Drug Discovery","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clostridium difficile; Intensive care medicine; Internal medicine; Metronidazole; Epidemiology; Cancer; Population; Antibiotics; Microbiology","score_opus":0.11854019939066347,"score_gpt":0.41874457819148553,"score_spread":0.30020437880082207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138614534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17183353,0.821931,0.00004538567,0.00019859115,0.0006541714,0.0048977765,0.00034325055,0.000022003287,0.00007430936],"genre_scores_gemma":[0.011967695,0.9859465,0.000020087837,0.000041042014,0.0002523491,0.0010258834,0.00046908378,0.000063894666,0.00021351334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613005,0.0006774802,0.0013771377,0.0008084958,0.00031215334,0.00069470215],"domain_scores_gemma":[0.9971994,0.000903056,0.00081989187,0.00040839057,0.0005224745,0.00014678441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001228041,0.00058634556,0.0018382957,0.00049162813,0.00020500101,0.000030432391,0.00011951486,0.00035593027,0.0000067265646],"category_scores_gemma":[0.0009394345,0.00038336072,0.0004545194,0.0005092468,0.00028433418,0.00018111728,0.00025585396,0.0005101751,0.0000049813975],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037973796,0.0016384206,0.023472562,0.012812833,0.00057472446,0.0000017111886,0.000019977171,0.000008091886,0.000039367507,0.0005204069,0.0006359413,0.9598962],"study_design_scores_gemma":[0.01103278,0.0038571246,0.21457301,0.06244298,0.0071632876,0.000016762015,0.00031849605,0.00022912306,0.001165162,0.0010233823,0.6961777,0.0020001733],"about_ca_topic_score_codex":0.0005658752,"about_ca_topic_score_gemma":0.0001536108,"teacher_disagreement_score":0.95789605,"about_ca_system_score_codex":0.0009556919,"about_ca_system_score_gemma":0.00020724421,"threshold_uncertainty_score":0.99986184},"labels":[],"label_agreement":null}]}